Patents by Inventor Ladan Fazli

Ladan Fazli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7863429
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: January 4, 2011
    Assignees: QLT Inc., Sunnybrook and Women's College and Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan, David W. C. Hunt, Jing-Song Tao, Ladan Fazli
  • Publication number: 20020155179
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Application
    Filed: November 30, 2001
    Publication date: October 24, 2002
    Inventors: Shoukat Dedhar, Greg Hannigan, David W.C. Hunt, Jing-Song Tao, Ladan Fazli